Skip to main content
Search
News, Views, and Advocacy From the Oncology Nursing Society
ONS Voice Home
  • News & Views
  • Advocacy
  • Stories
  • Twitter
  • LinkedIn
  • Instagram
  • News & Views
    • Latest Articles
    • Clinical Practice
    • ONS News
    • ONS Leadership
    Trending Topics
    • Research
    • Treatments
    • Safety
    • COVID-19
    • Drug Reference Sheet
    • Special Populations
    View All Topics
    Advocacy
    • Latest Articles
    • Get Involved
    Stories View All
    View All
    Learn How to Conduct Mock Code Simulations
    Clinical practice
    Learn How to Conduct Mock Code Simulations
    August 18, 2023
    Nurse-Led QI Project Standardizes Transplant and Cellular Therapy Nurse Coordinator Visit Scheduling
    Quality of care
    Nurse Practitioner's QI Project Standardizes Transplant and Cellular Therapy Nurse Coordinator Visit Scheduling
    August 03, 2023
    Nurse-Created Apps Help Pediatric Patients Find Their Voice and Navigate Their Cancer Journey
    Patient Support
    Nurse-Created Apps Help Pediatric Patients Find Their Voice and Navigate Their Cancer Journey
    July 21, 2023
    Certification Was a Critical Step Along My Oncology Nursing Career Journey
    Oncology nursing community
    Certification Was a Critical Step Along My Oncology Nursing Career Journey
    July 14, 2023
    Learn How to Read a Germline Genomic Testing Report
    Genetics & genomics
    Learn How to Read a Germline Genomic Testing Report
    July 07, 2023
    previous slide
    next slide
    Search
  • News & Views
  • Advocacy
  • Stories
    • Home

    Author Content

    APRNs Collaborate With PCPs on Shared Survivorship Care Models
    Advanced Practice Nursing (APRN)

    APRNs Collaborate With PCPs on Shared Survivorship Care Models

    Although they’ve conquered cancer, survivors may develop late or long-term physical, psychosocial, practical, or spiritual effects from the disease or its treatment. For example, patients with breast cancer who have completed surgery, radiation, or chemotherapy should be monitored for recurrence, lymphedema, osteoporosis, and cardiac, hormone-related, and sexual issues.

    September 08, 2022
    Break Bad News to Patients With This Step-by-Step Guide
    Advanced Practice Nursing (APRN)

    Break Bad News to Patients With This Step-by-Step Guide

    When hearing results from blood work or repeat imaging—regardless of whether they are “good” or “bad”—patients want and deserve to be given information truthfully and objectively. Oncology advanced practice providers are often the bearers of bad news, which can be uncomfortable and stressful. But here’s how you can hold those conversations with finesse, empathy, and respect.

    January 13, 2022
    Oncology Drug Reference Sheet: Amivantamab-Vmjw
    Drug Reference Sheet

    Oncology Drug Reference Sheet: Amivantamab-Vmjw

    After clinical trials demonstrated a 40% overall response rate with 63% of responses lasting six months or more, on May 21, 2021, the U.S. Food and Drug Administration (FDA) approved amivantamab-vmjw (RybrevantTM) for adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion variants, as detected by an FDA-approved test, whose disease has progressed on or after platinum-based chemotherapy.

    December 28, 2021

    To discuss the information in this article with other oncology nurses, visit the ONS Communities.

    To report a content error, inaccuracy, or typo, email pubONSVoice@ons.org.

    Aileen Anglin APRN, ACNP-BC, AOCNP®
     
    Home
    News, Views, and Advocacy From the Oncology Nursing Society
  • Legal Notices
  • Contact Us
  • Conferences
  • Advertising
  • Newsroom
  • Sitemap
  • Twitter
  • LinkedIn
  • Instagram
  • ONS
  • Oncology Nursing Foundation
  • ONCC
  • © Copyright 2023 Oncology Nursing Society
     
    Back to Top ▲